{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:10:10Z","timestamp":1791155410374,"version":"4.1.0"},"reference-count":32,"publisher":"EDP Sciences","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1051\/medsci\/2007234386","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T11:11:29Z","timestamp":1299323489000},"page":"386-390","source":"Crossref","is-referenced-by-count":9,"title":["L\u2019apport des nouvelles technologies en vaccinologie"],"prefix":"10.1051","volume":"23","author":[{"given":"Claude","family":"Leclerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2007,4,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Lowe DB, Shearer MH, Kennedy RC. DNA vaccines: successes and limitations in cancer and infectious disease.J Cell Biochem2006; 98 : 235\u201342.","DOI":"10.1002\/jcb.20775"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Cui Z. DNA vaccine.Adv Genet2005; 54 : 257\u201389.","DOI":"10.1016\/S0065-2660(05)54011-2"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Lorin C, Delebecque F, Labrousse V,et al.A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes.Vaccine2005; 23 : 4463\u201372.","DOI":"10.1016\/j.vaccine.2005.04.024"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Lai CJ, Monath TP. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.Adv Virus Res2003; 61 : 469\u2013509.","DOI":"10.1016\/S0065-3527(03)61013-4"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Girard MP, Osmanov SK, Kieny MP. A review of vaccine research and development: the human immunodeficiency virus (HIV).Vaccine2006; 24 : 4062\u201381.","DOI":"10.1016\/j.vaccine.2006.02.031"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Kaufmann SH. Envisioning future strategies for vaccination against tuberculosis.Nat Rev Immunol2006; 6 : 699\u2013704.","DOI":"10.1038\/nri1920"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Li S, Locke E, Bruder J,et al.Viral vectors for malaria vaccine development.Vaccine2007 (sous presse).","DOI":"10.1016\/j.vaccine.2006.07.035"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Querec T, Bennouna S, Alkan S,et al.Yellow fever vaccine YF-17D activates multiple dendritic cell subsetsviaTLR2, 7, 8, and 9 to stimulate polyvalent immunity.J Exp Med2006; 203 : 413\u201324.","DOI":"10.1084\/jem.20051720"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Napolitani G, Rinaldi A, Bertoni F,et al.Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.Nat Immunol2005; 6 : 769\u201376.","DOI":"10.1038\/ni1223"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Bangari DS, Mittal SK. Development of nonhuman adenoviruses as vaccine vectors.Vaccine2006; 24 : 849\u201362.","DOI":"10.1016\/j.vaccine.2005.08.101"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Roberts DM, Nanda A, Havenga MJ,et al.Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.Nature2006; 441 : 239\u201343.","DOI":"10.1038\/nature04721"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Woodland DL. Jump-starting the immune system: prime-boosting comes of age.Trends Immunol2004; 25 : 98\u2013104.","DOI":"10.1016\/j.it.2003.11.009"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Amara RR, Villinger F, Altman JD,et al.Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine.Science2001; 292 : 69\u201374.","DOI":"10.1126\/science.1058915"},{"key":"R14","unstructured":"Shiver JW, Fu TM,. Chen L,et al.Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.Nature2002; 415 : 331\u20135."},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Vuola JM, Keating S, Webster DP,et al.Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.J Immunol2005; 174 : 449\u201355.","DOI":"10.4049\/jimmunol.174.1.449"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Masopust D., Ha SJ, Vezys V,et al.Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination.J Immunol2006; 177 : 831\u20139.","DOI":"10.4049\/jimmunol.177.2.831"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Bonifaz L, D Bonnyay, K Mahnke,et al.Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+T cell tolerance.J Exp Med2002; 196 : 1627\u201338.","DOI":"10.1084\/jem.20021598"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Bonifaz LC, Bonnyay DP, Charalambous A,et al.In vivotargeting of antigens to maturing dendritic cellsviathe DEC-205 receptor improves T cell vaccination.J Exp Med2004; 199 : 815\u201324.","DOI":"10.1084\/jem.20032220"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Trumpfheller C, Finke JS, Lopez CB,et al.Intensified and protective CD4+T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.J Exp Med2006; 203 : 607\u201317.","DOI":"10.1084\/jem.20052005"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Boscardin SB, Hafalla JC, Masilamani RF,et al.Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses.J Exp Med2006; 203 : 599\u2013606.","DOI":"10.1084\/jem.20051639"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Corbett AJ, Caminschi I, McKenzie BS,et al.Antigen delivery via two molecules on the CD8-dendritic cell subset induces humoral immunity in the absence of conventional \u00ab danger \u00bb.Eur J Immunol2005; 35 : 2815\u201325.","DOI":"10.1002\/eji.200526100"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Tacken PJ, de Vries IJ, Gijzen K,et al.Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cellsviaa humanized anti-DC-SIGN antibody.Blood2005; 106 : 1278\u201385.","DOI":"10.1182\/blood-2005-01-0318"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Guermonprez P., Khelef N, Blouin E,et al.The adenylate cyclase toxin of Bordetella pertussis binds to target cellsviathe alpha(M)beta(2) integrin (CD11b\/CD18).J Exp Med2001; 193 : 1035\u201344.","DOI":"10.1084\/jem.193.9.1035"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Guermonprez P, Fayolle C,. Rojas MJ,et al.In vivoreceptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c+CD8 alpha-CD11bhigh dendritic cells.Eur J Immunol2002; 32 : 3071\u201381.","DOI":"10.1002\/1521-4141(200211)32:11<3071::AID-IMMU3071>3.0.CO;2-A"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Saron MF, Fayolle C, Sebo P,et al.Anti-viral protection conferred by recombinant adenylate cyclase toxins fromBordetella pertussiscarrying a CD8+T cell epitope from lymphocytic choriomeningitis virus.Proc Natl Acad Sci USA1997; 94 : 3314\u20139.","DOI":"10.1073\/pnas.94.7.3314"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Mascarell L, Fayolle C, Bauche C,et al.Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase ofBordetella pertussis. J Virol2005; 79 : 9872\u201384.","DOI":"10.1128\/JVI.79.15.9872-9884.2005"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Mascarell L, Bauche C, Fayolle C,et al.Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates.Vaccine2006; 24 : 3490\u20139.","DOI":"10.1016\/j.vaccine.2006.02.009"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Preville X, Ladant D, Timmerman B,et al.Eradication of established tumors by vaccination with recombinantBordetella pertussisadenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.Cancer Res2005 : 65 : 641\u20139.","DOI":"10.1158\/0008-5472.641.65.2"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Vingert B., Adotevi O, Patin D,et al.The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity.Eur J Immunol2006; 36 : 1124\u201335.","DOI":"10.1002\/eji.200535443"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Lu Y, Friedman R, Kushner N,et al.Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity.Proc Natl Acad Sci USA2000; 97 : 8027\u201332.","DOI":"10.1073\/pnas.97.14.8027"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Basu S, Binder RJ, Ramalingam T,et al.CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.Immunity2001; 14 : 303\u201313.","DOI":"10.1016\/S1074-7613(01)00111-X"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Hauser H, Shen L, Gu QL,et al.Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines.Gene Ther2004; 11 : 924\u201332.","DOI":"10.1038\/sj.gt.3302160"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2007234386\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T14:18:33Z","timestamp":1685974713000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2007234386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":32,"journal-issue":{"issue":"4"},"alternative-id":["medsci2007234p386"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2007234386","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}